Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review
Background: People suffering from schizophrenia are notably vulnerable to cardiometabolic risk factors (CMRF), such as obesity, high blood pressure, hyperglycemia and insulin resistance, high serum triglycerides, and low serum high-density lipoprotein (HDL), which are related to increased mortality...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2019-08-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2019.00566/full |
| _version_ | 1818483154261901312 |
|---|---|
| author | Ewa Tumiel Adam Wichniak Marek Jarema Michał Lew-Starowicz Michał Lew-Starowicz |
| author_facet | Ewa Tumiel Adam Wichniak Marek Jarema Michał Lew-Starowicz Michał Lew-Starowicz |
| author_sort | Ewa Tumiel |
| collection | DOAJ |
| description | Background: People suffering from schizophrenia are notably vulnerable to cardiometabolic risk factors (CMRF), such as obesity, high blood pressure, hyperglycemia and insulin resistance, high serum triglycerides, and low serum high-density lipoprotein (HDL), which are related to increased mortality and decreased quality of life. The increased risk of “metabolic syndrome” (MS) is related to low physical activity, an unhealthy diet, and side effects of antipsychotic drugs. Nonpharmacological interventions seem to be important in the prevention and therapy of MS.Aim: This paper provides an overview of published studies and a critical analysis of pilot programs involving nonpharmacological measures aimed at prevention and treatment of CMRF in patients with schizophrenia.Material and Method: We searched the PubMed, PsycARTICLES, and Cochrane Library databases to identify clinical trials. We included full-text studies that met the following criteria: age > 18 years, a diagnosis of schizophrenia or schizoaffective disorder, and monitored parameters associated with MS.Results: All 1,555 references were evaluated for inclusion in the review, and 20 met the inclusion criteria. Nonpharmacological interventions led to improvement in physical health and showed a promising potential for implementation in treatment programs dedicated to this particular group of patients. However, a critical analysis revealed limitations, which have implications for the direction of future research.Conclusions: Patients suffering from schizophrenia can benefit from nonpharmacological interventions aimed at counteracting CMRF, improving either metabolic parameters, cardiovascular fitness, or their health perception. Notwithstanding, to achieve long-term effects, future studies should comprise appropriate follow-up procedures. |
| first_indexed | 2024-12-10T11:56:35Z |
| format | Article |
| id | doaj.art-c57d9fe43a1a4887b72613ade9eeb772 |
| institution | Directory Open Access Journal |
| issn | 1664-0640 |
| language | English |
| last_indexed | 2024-12-10T11:56:35Z |
| publishDate | 2019-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Psychiatry |
| spelling | doaj.art-c57d9fe43a1a4887b72613ade9eeb7722022-12-22T01:49:45ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402019-08-011010.3389/fpsyt.2019.00566430950Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic ReviewEwa Tumiel0Adam Wichniak1Marek Jarema2Michał Lew-Starowicz3Michał Lew-Starowicz4III Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, PolandIII Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, PolandIII Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, PolandIII Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, PolandDepartment of Psychiatry, Centre of Postgraduate Medical Education, Warsaw, PolandBackground: People suffering from schizophrenia are notably vulnerable to cardiometabolic risk factors (CMRF), such as obesity, high blood pressure, hyperglycemia and insulin resistance, high serum triglycerides, and low serum high-density lipoprotein (HDL), which are related to increased mortality and decreased quality of life. The increased risk of “metabolic syndrome” (MS) is related to low physical activity, an unhealthy diet, and side effects of antipsychotic drugs. Nonpharmacological interventions seem to be important in the prevention and therapy of MS.Aim: This paper provides an overview of published studies and a critical analysis of pilot programs involving nonpharmacological measures aimed at prevention and treatment of CMRF in patients with schizophrenia.Material and Method: We searched the PubMed, PsycARTICLES, and Cochrane Library databases to identify clinical trials. We included full-text studies that met the following criteria: age > 18 years, a diagnosis of schizophrenia or schizoaffective disorder, and monitored parameters associated with MS.Results: All 1,555 references were evaluated for inclusion in the review, and 20 met the inclusion criteria. Nonpharmacological interventions led to improvement in physical health and showed a promising potential for implementation in treatment programs dedicated to this particular group of patients. However, a critical analysis revealed limitations, which have implications for the direction of future research.Conclusions: Patients suffering from schizophrenia can benefit from nonpharmacological interventions aimed at counteracting CMRF, improving either metabolic parameters, cardiovascular fitness, or their health perception. Notwithstanding, to achieve long-term effects, future studies should comprise appropriate follow-up procedures.https://www.frontiersin.org/article/10.3389/fpsyt.2019.00566/fullschizophreniametabolic syndromecardiometabolic risk factorsexercisedietpsychotherapy |
| spellingShingle | Ewa Tumiel Adam Wichniak Marek Jarema Michał Lew-Starowicz Michał Lew-Starowicz Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review Frontiers in Psychiatry schizophrenia metabolic syndrome cardiometabolic risk factors exercise diet psychotherapy |
| title | Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review |
| title_full | Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review |
| title_fullStr | Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review |
| title_full_unstemmed | Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review |
| title_short | Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review |
| title_sort | nonpharmacological interventions for the treatment of cardiometabolic risk factors in people with schizophrenia a systematic review |
| topic | schizophrenia metabolic syndrome cardiometabolic risk factors exercise diet psychotherapy |
| url | https://www.frontiersin.org/article/10.3389/fpsyt.2019.00566/full |
| work_keys_str_mv | AT ewatumiel nonpharmacologicalinterventionsforthetreatmentofcardiometabolicriskfactorsinpeoplewithschizophreniaasystematicreview AT adamwichniak nonpharmacologicalinterventionsforthetreatmentofcardiometabolicriskfactorsinpeoplewithschizophreniaasystematicreview AT marekjarema nonpharmacologicalinterventionsforthetreatmentofcardiometabolicriskfactorsinpeoplewithschizophreniaasystematicreview AT michałlewstarowicz nonpharmacologicalinterventionsforthetreatmentofcardiometabolicriskfactorsinpeoplewithschizophreniaasystematicreview AT michałlewstarowicz nonpharmacologicalinterventionsforthetreatmentofcardiometabolicriskfactorsinpeoplewithschizophreniaasystematicreview |